Establishment of Induced Pluripotent Stem Cell Line (Zzui010-A) from an Alzheimer's Disease Patient Carrying an APP Gene Mutation.

Zhilei Wang,Pei Zhang,Yanlin Wang,Changhe Shi,Na Jing,Huifang Sun,Jing Yang,Yutao Liu,Xuejun Wen,Jin Zhang,Shoutao Zhang,Yuming Xu

DOI: https://doi.org/10.1016/j.scr.2017.10.025

IF: 1.587

2017-01-01

Stem Cell Research

Abstract:Alzheimer's disease (AD) is one of the most common neurodegenerative disorders. Previous studies have identified mutations in several genes, such as amyloid precursor protein (APP), presenilin-1 (PSEN1), and presenilin-2 (PSEN2), in patients with early-onset (<65years) familial AD. Recently, a patient with an APP gene mutation was identified; the dermal fibroblasts of the patient were obtained and a line of induced pluripotent stem cells (iPSCs) was successfully generated using the Sendai-virus (SeV) delivery system. The iPSC line will be useful for further study of the pathomechanism and drug screening for AD.